SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.13-0.5%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (7915)12/2/1998 3:50:00 PM
From: aknahow  Read Replies (1) of 17367
 
Bob, 3 for 4.

Factsheet Updated.

November 1998

Index

Company Description
Financial Data
NEUPREX®
NEUPREX® Clinical Program
R & D
Management
Product Pipeline

NEUPREX® Phase III
Clinical Trial Update:

Meningococcemia:
> 285 patients enrolled
UK and US

Hemorrhage/trauma:
> 460 patients in 40
trauma centers
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News